BRO vs DAWN · P/E 30, rev $3.58B vs rev $131.2M
Brown & Brown Inc (BRO) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the BRO and DAWN stock pages for the full models.
Not investment advice.